BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 8964817)

  • 1. From graphical analysis to multilinear regression analysis of reversible radioligand binding.
    Ichise M; Ballinger JR
    J Cereb Blood Flow Metab; 1996 Jul; 16(4):750-2. PubMed ID: 8964817
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of volume of distribution using likelihood estimation in graphical analysis: elimination of estimation bias.
    Parsey RV; Ogden RT; Mann JJ
    J Cereb Blood Flow Metab; 2003 Dec; 23(12):1471-8. PubMed ID: 14663343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved statistical power of the multilinear reference tissue approach to the quantification of neuroreceptor ligand binding by regularization.
    Buchert R; Wilke F; van den Hoff J; Mester J
    J Cereb Blood Flow Metab; 2003 May; 23(5):612-20. PubMed ID: 12771577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lithiation of functionalized fluoroquinolines: synthesis of dihalo-2-phenylquinoline-4-carboxamides and in vitro evaluation as NK-3 receptor ligands for medical imaging studies.
    Bennacef I; Tymciu S; Dhilly M; Mongin F; Quéguiner G; Lasne MC; Barré L; Perrio C
    J Org Chem; 2004 Apr; 69(7):2622-5. PubMed ID: 15049675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of halogenated naphthyridone carboxamides as potential ligands for in vivo imaging studies of substance P receptors.
    Bagot-Guéret C; Le Bas MD; Tymciu S; Darabantu M; Emond P; Guilloteau D; Lasne MC; Wijkhuisen A; Barré L; Perrio C
    Bioconjug Chem; 2003; 14(3):629-41. PubMed ID: 12757389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular transport mechanisms of radiolabeled amino acids for PET and SPECT.
    Langen KJ; Bröer S
    J Nucl Med; 2004 Sep; 45(9):1435-6. PubMed ID: 15347708
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of noninvasive quantification methods of in vivo vesicular acetylcholine transporter using [123I]-IBVM SPECT imaging.
    Barret O; Mazère J; Seibyl J; Allard M
    J Cereb Blood Flow Metab; 2008 Sep; 28(9):1624-34. PubMed ID: 18506194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease.
    Kung MP; Hou C; Zhuang ZP; Skovronsky D; Kung HF
    Brain Res; 2004 Oct; 1025(1-2):98-105. PubMed ID: 15464749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An introduction to PET and SPECT neuroreceptor quantification models.
    Ichise M; Meyer JH; Yonekura Y
    J Nucl Med; 2001 May; 42(5):755-63. PubMed ID: 11337572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactive compartmental modeling.
    Kuikka JT
    J Nucl Med; 1998 Sep; 39(9):1649. PubMed ID: 9744363
    [No Abstract]   [Full Text] [Related]  

  • 11. Positron emission tomography compartmental models.
    Gunn RN; Gunn SR; Cunningham VJ
    J Cereb Blood Flow Metab; 2001 Jun; 21(6):635-52. PubMed ID: 11488533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic considerations in the PET and SPECT evaluation of CNS receptors.
    Mazière B; Delforge J
    Q J Nucl Med; 1997 Jun; 41(2):119-26. PubMed ID: 9203851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for the labeling of halogen-substituted peroxisome proliferator-activated receptor gamma ligands: potential positron emission tomography and single photon emission computed tomography imaging agents.
    Lee BC; Lee KC; Lee H; Mach RH; Katzenellenbogen JA
    Bioconjug Chem; 2007; 18(2):514-23. PubMed ID: 17315977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of amphetamine-induced changes in [11C]raclopride binding with continuous infusion.
    Carson RE; Breier A; de Bartolomeis A; Saunders RC; Su TP; Schmall B; Der MG; Pickar D; Eckelman WC
    J Cereb Blood Flow Metab; 1997 Apr; 17(4):437-47. PubMed ID: 9143226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain radioligands--state of the art and new trends.
    Halldin C; Gulyás B; Langer O; Farde L
    Q J Nucl Med; 2001 Jun; 45(2):139-52. PubMed ID: 11476163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting peptides and positron emission tomography.
    Lundqvist H; Tolmachev V
    Biopolymers; 2002; 66(6):381-92. PubMed ID: 12658725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of kinetic parameters in graphical analysis of PET imaging data.
    Ogden RT
    Stat Med; 2003 Nov; 22(22):3557-68. PubMed ID: 14601019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developments in instrumentation for emission computed tomography.
    Daube-Witherspoon ME; Zubal IG; Karp JS
    Semin Nucl Med; 2003 Jan; 33(1):28-41. PubMed ID: 12605355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic imaging and tracer kinetic modeling for emission tomography using rotating detectors.
    Lau CH; Feng D; Hutton BF; Lun DP; Siu WC
    IEEE Trans Med Imaging; 1998 Dec; 17(6):986-94. PubMed ID: 10048855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, labeling, and biological evaluation of halogenated 2-quinolinecarboxamides as potential radioligands for the visualization of peripheral benzodiazepine receptors.
    Cappelli A; Matarrese M; Moresco RM; Valenti S; Anzini M; Vomero S; Turolla EA; Belloli S; Simonelli P; Filannino MA; Lecchi M; Fazio F
    Bioorg Med Chem; 2006 Jun; 14(12):4055-66. PubMed ID: 16495062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.